Increased fasting small-bowel water content in untreated coeliac disease and scleroderma as assessed by magnetic resonance imaging. (2019)
Attributed to:
Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome(IBS-D)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1177/2050640619860372
PubMed Identifier: 31839961
Publication URI: http://europepmc.org/abstract/MED/31839961
Type: Journal Article/Review
Volume: 7
Parent Publication: United European gastroenterology journal
Issue: 10
ISSN: 2050-6406